PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
43.00%
Revenue growth under 50% of FSLR's 101.94%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
23.23%
Gross profit growth under 50% of FSLR's 101.94%. Michael Burry would be concerned about a severe competitive disadvantage.
49.67%
EBIT growth below 50% of FSLR's 169.84%. Michael Burry would suspect deeper competitive or cost structure issues.
49.67%
Operating income growth under 50% of FSLR's 169.84%. Michael Burry would be concerned about deeper cost or sales issues.
139.84%
Net income growth above 1.5x FSLR's 81.19%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
110.69%
EPS growth 1.25-1.5x FSLR's 83.20%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
109.67%
Diluted EPS growth 1.25-1.5x FSLR's 83.20%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
162.28%
Share count expansion well above FSLR's 10.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
187.19%
Diluted share count expanding well above FSLR's 10.05%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-7700.00%
Negative OCF growth while FSLR is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.87%
Negative FCF growth while FSLR is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-78.34%
Negative 10Y revenue/share CAGR while FSLR stands at 551.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-78.34%
Negative 5Y CAGR while FSLR stands at 551.85%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-78.34%
Negative 3Y CAGR while FSLR stands at 551.85%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
97.87%
OCF/share CAGR of 97.87% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
97.87%
OCF/share CAGR of 97.87% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
97.87%
3Y OCF/share CAGR of 97.87% while FSLR is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
100.20%
Net income/share CAGR 1.25-1.5x FSLR's 74.03%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
100.20%
5Y net income/share CAGR 1.25-1.5x FSLR's 74.03%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
100.20%
3Y net income/share CAGR 1.25-1.5x FSLR's 74.03%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.40%
AR growth of 25.40% while FSLR is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
31.67%
Inventory growth of 31.67% while FSLR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.21%
Asset growth of 4.21% while FSLR is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
-61.69%
We have a declining book value while FSLR shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
234.90%
R&D growth of 234.90% while FSLR is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
329.37%
SG&A growth of 329.37% while FSLR is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.